About Evvy

Evvy offers at-home vaginal microbiome tests utilizing metagenomic sequencing to provide insights into symptoms related to infections, fertility, and other health outcomes. The tests deliver preliminary results within 1-3 days and include personalized care plans and prescription treatment options based on individual findings.

```xml <problem> Many individuals with vaginas experience recurring or persistent vaginal health issues, such as infections and imbalances, that are difficult to diagnose and treat effectively with standard clinical methods. Traditional testing often provides incomplete information about the vaginal microbiome, leading to inadequate or ineffective treatments. The lack of comprehensive understanding of the vaginal microbiome contributes to delayed diagnoses and prolonged discomfort for many individuals. </problem> <solution> Evvy offers an at-home vaginal microbiome test that utilizes metagenomic sequencing to provide a comprehensive analysis of the bacteria, fungi, and other microorganisms present in the vaginal environment. This advanced testing method identifies the specific composition of the vaginal microbiome, offering insights into the root causes of symptoms related to infections, fertility, and overall vaginal health. Based on the test results, Evvy provides personalized care plans, including evidence-based recommendations and prescription treatment options, tailored to address individual needs and restore microbial balance. The platform also offers ongoing tracking and monitoring to assess the impact of treatments and lifestyle changes on the vaginal microbiome. </solution> <features> - At-home vaginal microbiome test using CLIA-certified metagenomic sequencing for comprehensive analysis. - Identification of all bacteria, fungi, and other microorganisms in the vaginal microbiome. - Personalized care plans with clear next steps based on individual test results. - Prescription treatment programs developed by Evvy-affiliated providers (where eligible). - Access to science-backed education, community support, and 1:1 coaching. - Proactive tracking of the vaginal microbiome to monitor the impact of treatments and behaviors. - Option to add an STI + PCR panel for comprehensive screening. </features> <target_audience> Evvy primarily targets women and individuals with vaginas experiencing vaginal health issues, such as recurrent infections, fertility challenges, or general imbalances, who are seeking comprehensive insights and personalized solutions. </target_audience> <revenue_model> Evvy generates revenue through the sale of its at-home vaginal microbiome tests, offered as both one-time purchases and subscription plans, with options to add additional testing panels or personalized care programs. </revenue_model> ```

What does Evvy do?

How much funding has Evvy raised?

Evvy has raised 14000000.

Funding

14000000

Employees

60 employees

Major Investors

Left Lane Capital

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Evvy

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

evvy.com 10K+

Crunchbase

Funding

Estimated Funding

$10M+

Major Investors

Left Lane Capital

Team (50+)

No team information available.

Company Description

Problem

Many individuals with vaginas experience recurring or persistent vaginal health issues, such as infections and imbalances, that are difficult to diagnose and treat effectively with standard clinical methods. Traditional testing often provides incomplete information about the vaginal microbiome, leading to inadequate or ineffective treatments. The lack of comprehensive understanding of the vaginal microbiome contributes to delayed diagnoses and prolonged discomfort for many individuals.

Solution

Evvy offers an at-home vaginal microbiome test that utilizes metagenomic sequencing to provide a comprehensive analysis of the bacteria, fungi, and other microorganisms present in the vaginal environment. This advanced testing method identifies the specific composition of the vaginal microbiome, offering insights into the root causes of symptoms related to infections, fertility, and overall vaginal health. Based on the test results, Evvy provides personalized care plans, including evidence-based recommendations and prescription treatment options, tailored to address individual needs and restore microbial balance. The platform also offers ongoing tracking and monitoring to assess the impact of treatments and lifestyle changes on the vaginal microbiome.

Features

At-home vaginal microbiome test using CLIA-certified metagenomic sequencing for comprehensive analysis.

Identification of all bacteria, fungi, and other microorganisms in the vaginal microbiome.

Personalized care plans with clear next steps based on individual test results.

Prescription treatment programs developed by Evvy-affiliated providers (where eligible).

Access to science-backed education, community support, and 1:1 coaching.

Proactive tracking of the vaginal microbiome to monitor the impact of treatments and behaviors.

Option to add an STI + PCR panel for comprehensive screening.

Target Audience

Evvy primarily targets women and individuals with vaginas experiencing vaginal health issues, such as recurrent infections, fertility challenges, or general imbalances, who are seeking comprehensive insights and personalized solutions.

Revenue Model

Evvy generates revenue through the sale of its at-home vaginal microbiome tests, offered as both one-time purchases and subscription plans, with options to add additional testing panels or personalized care programs.